220 related articles for article (PubMed ID: 30925701)
1. Comprehensive Genomic Profiling of Androgen-Receptor-Negative Canine Prostate Cancer.
Laufer-Amorim R; Fonseca-Alves CE; Villacis RAR; Linde SAD; Carvalho M; Larsen SJ; Marchi FA; Rogatto SR
Int J Mol Sci; 2019 Mar; 20(7):. PubMed ID: 30925701
[TBL] [Abstract][Full Text] [Related]
2. Alterations in PTEN, MDM2, TP53 and AR protein and gene expression are associated with canine prostate carcinogenesis.
Rivera-Calderón LG; Fonseca-Alves CE; Kobayashi PE; Carvalho M; Drigo SA; de Oliveira Vasconcelos R; Laufer-Amorim R
Res Vet Sci; 2016 Jun; 106():56-61. PubMed ID: 27234536
[TBL] [Abstract][Full Text] [Related]
3. Altered expression of p53, but not Rb, is involved in canine prostatic carcinogenesis.
Pagliarone S; Frattone L; Pirocchi V; Della Salda L; Palmieri C
Res Vet Sci; 2016 Apr; 105():195-9. PubMed ID: 27033932
[TBL] [Abstract][Full Text] [Related]
4. Characterization of canine osteosarcoma by array comparative genomic hybridization and RT-qPCR: signatures of genomic imbalance in canine osteosarcoma parallel the human counterpart.
Angstadt AY; Motsinger-Reif A; Thomas R; Kisseberth WC; Guillermo Couto C; Duval DL; Nielsen DM; Modiano JF; Breen M
Genes Chromosomes Cancer; 2011 Nov; 50(11):859-74. PubMed ID: 21837709
[TBL] [Abstract][Full Text] [Related]
5. Investigation of c-KIT and Ki67 expression in normal, preneoplastic and neoplastic canine prostate.
Fonseca-Alves CE; Kobayashi PE; Palmieri C; Laufer-Amorim R
BMC Vet Res; 2017 Dec; 13(1):380. PubMed ID: 29207991
[TBL] [Abstract][Full Text] [Related]
6. DNA copy number alterations, gene expression changes and disease-free survival in patients with colorectal cancer: a 10 year follow-up.
Bigagli E; De Filippo C; Castagnini C; Toti S; Acquadro F; Giudici F; Fazi M; Dolara P; Messerini L; Tonelli F; Luceri C
Cell Oncol (Dordr); 2016 Dec; 39(6):545-558. PubMed ID: 27709558
[TBL] [Abstract][Full Text] [Related]
7. Molecular cloning of canine co-chaperone small glutamine-rich tetratricopeptide repeat-containing protein α (SGTA) and investigation of its ability to suppress androgen receptor signalling in androgen-independent prostate cancer.
Kato Y; Ochiai K; Michishita M; Azakami D; Nakahira R; Morimatsu M; Ishiguro-Oonuma T; Yoshikawa Y; Kobayashi M; Bonkobara M; Kobayashi M; Takahashi K; Watanabe M; Omi T
Vet J; 2015 Nov; 206(2):143-8. PubMed ID: 26346258
[TBL] [Abstract][Full Text] [Related]
8. Detection of novel amplicons in prostate cancer by comprehensive genomic profiling of prostate cancer cell lines using oligonucleotide-based arrayCGH.
Kamradt J; Jung V; Wahrheit K; Tolosi L; Rahnenfuehrer J; Schilling M; Walker R; Davis S; Stoeckle M; Meltzer P; Wullich B
PLoS One; 2007 Aug; 2(8):e769. PubMed ID: 17712417
[TBL] [Abstract][Full Text] [Related]
9. Cribriform and intraductal prostate cancer are associated with increased genomic instability and distinct genomic alterations.
Böttcher R; Kweldam CF; Livingstone J; Lalonde E; Yamaguchi TN; Huang V; Yousif F; Fraser M; Bristow RG; van der Kwast T; Boutros PC; Jenster G; van Leenders GJLH
BMC Cancer; 2018 Jan; 18(1):8. PubMed ID: 29295717
[TBL] [Abstract][Full Text] [Related]
10. Association between genomic alterations and metastatic behavior of colorectal cancer identified by array-based comparative genomic hybridization.
Sawada T; Yamamoto E; Suzuki H; Nojima M; Maruyama R; Shioi Y; Akasaka R; Kamimae S; Harada T; Ashida M; Kai M; Adachi Y; Yamamoto H; Imai K; Toyota M; Itoh F; Sugai T
Genes Chromosomes Cancer; 2013 Feb; 52(2):140-9. PubMed ID: 23073979
[TBL] [Abstract][Full Text] [Related]
11. A genome-wide approach to comparative oncology: high-resolution oligonucleotide aCGH of canine and human osteosarcoma pinpoints shared microaberrations.
Angstadt AY; Thayanithy V; Subramanian S; Modiano JF; Breen M
Cancer Genet; 2012 Nov; 205(11):572-87. PubMed ID: 23137772
[TBL] [Abstract][Full Text] [Related]
12. Genomic copy number variation associated with clinical outcome in canine cutaneous mast cell tumors.
Jark PC; Mundin DB; de Carvalho M; Ferioli RB; Anai LA; Marchi FA; Rogatto SR; Laufer-Amorim R; Tinucci-Costa M
Res Vet Sci; 2017 Apr; 111():26-30. PubMed ID: 28266316
[TBL] [Abstract][Full Text] [Related]
13. Androgen receptor CAG repeat polymorphisms in canine prostate cancer.
Lai CL; L'Eplattenier H; van den Ham R; Verseijden F; Jagtenberg A; Mol JA; Teske E
J Vet Intern Med; 2008; 22(6):1380-4. PubMed ID: 18783352
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of NKX3.1 and C-MYC expression in canine prostatic cancer.
Fonseca-Alves CE; Kobayashi PE; Laufer-Amorim R
Res Vet Sci; 2018 Jun; 118():365-370. PubMed ID: 29665565
[TBL] [Abstract][Full Text] [Related]
15. Genome-wide assessment of recurrent genomic imbalances in canine leukemia identifies evolutionarily conserved regions for subtype differentiation.
Roode SC; Rotroff D; Avery AC; Suter SE; Bienzle D; Schiffman JD; Motsinger-Reif A; Breen M
Chromosome Res; 2015 Dec; 23(4):681-708. PubMed ID: 26037708
[TBL] [Abstract][Full Text] [Related]
16. Genomic profiling of canine mast cell tumors identifies DNA copy number aberrations associated with KIT mutations and high histological grade.
Mochizuki H; Thomas R; Moroff S; Breen M
Chromosome Res; 2017 Jun; 25(2):129-143. PubMed ID: 28058543
[TBL] [Abstract][Full Text] [Related]
17. Genomic profiling reveals extensive heterogeneity in somatic DNA copy number aberrations of canine hemangiosarcoma.
Thomas R; Borst L; Rotroff D; Motsinger-Reif A; Lindblad-Toh K; Modiano JF; Breen M
Chromosome Res; 2014 Sep; 22(3):305-19. PubMed ID: 24599718
[TBL] [Abstract][Full Text] [Related]
18. P-Glycoprotein and Androgen Receptor Expression Reveals Independence of Canine Prostate Cancer from Androgen Hormone Stimulation.
Cavalca AMB; Brandi A; Fonseca-Alves RH; Laufer-Amorim R; Fonseca-Alves CE
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163087
[TBL] [Abstract][Full Text] [Related]
19. Cells Comprising the Prostate Cancer Microenvironment Lack Recurrent Clonal Somatic Genomic Aberrations.
Bianchi-Frias D; Basom R; Delrow JJ; Coleman IM; Dakhova O; Qu X; Fang M; Franco OE; Ericson NG; Bielas JH; Hayward SW; True L; Morrissey C; Brown L; Bhowmick NA; Rowley D; Ittmann M; Nelson PS
Mol Cancer Res; 2016 Apr; 14(4):374-84. PubMed ID: 26753621
[TBL] [Abstract][Full Text] [Related]
20. Morphological and Molecular Characterization of Proliferative Inflammatory Atrophy in Canine Prostatic Samples.
de Godoy Fernandes G; Pedrina B; de Faria Lainetti P; Kobayashi PE; Govoni VM; Palmieri C; de Moura VMBD; Laufer-Amorim R; Fonseca-Alves CE
Cancers (Basel); 2021 Apr; 13(8):. PubMed ID: 33920045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
